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The crystal structure and pro-inﬂammatory property of a lectin from the seeds of Dioclea wilsonii (DwL)
were analyzed to gain a better understanding of structure/function relationships of Diocleinae lectins.
Following crystallization and structural determination by standard molecular replacement techniques,
DwL was found to be a tetramer based on PISA analysis, and composed by two metal-binding sites per
monomer and loops which are involved in molecular oligomerization. DwL presents 96% and 99%
identity with two other previously described lectins of Dioclea rostrata (DRL) and Dioclea grandiﬂora
(DGL). DwL differs structurally from DVL and DRL with regard to the conformation of the carbohydrate
recognition domain and related biological activities. The structural analysis of DwL in comparison to
other Diocleinae lectins can be related to the differences in the dose-dependent pro-inﬂammatory effect
elicited in Wistar rats, probably via speciﬁc interactions with mast cells complex carbohydrate, resulting
in signiﬁcant paw edema. DwL appears to be involved in positive modulation of mast cell degranulation
via recognition of surface carbohydrates. Since this recognition is dependent on site volume and CRD
conﬁguration, edematogenesis mediated by resident cells varies in potency and efﬁcacy among different
Diocleinae lectins.
 2011 Elsevier Masson SAS. Open access under the Elsevier OA license.1. Introduction
Lectins are ubiquitous proteins or glycoproteins with at least one
non-catalytic domain binding reversibly to a speciﬁc mono- or
oligosaccharide [1]. Due to their ability to decipher membrane gly-
cocodes, lectins participate in numerous cellular processes, such as
cell communication, host defense, fertilization and development [2].
Diocleinae lectins exhibit glucose/mannose-monosaccharide
binding speciﬁcity. Studies of their chemical and physicochemicalto de Bioquímica e Biologia
Hull S/N, P.O. Box 6043, Zip
5 85 3366 9818.
nder the Elsevier OA license.properties have revealed a high degree of similarity in amino acid
sequence and three-dimensional structure [3]. A comparative study
of the primary structure of lectins from the genera Canavalia, Dio-
clea and Cratylia (subtribe Diocleinae) indicated the existence of
regions speciﬁc to each genus, evidencing different branches in the
evolutionary tree [4]. Despite great structural similarities, these
lectins express a wide range of biological activities with varying
potency and efﬁcacy [5].
Concanavalin A (ConA) is the most studied Diocleinae lectin.
Thus, many of its structures have already been deposited in the PDB
with different ligands (mono- and oligosaccharides). The observed
differences in interactions within the carbohydrate-binding site of
Diocleinae lectins may help clarify the correlation between struc-
ture and physiological function [5,6]. The spatial distribution of
carbohydrate-binding sites in oligomeric lectins determines their
T.B.A. Rangel et al. / Biochimie 94 (2012) 525e532526ability to distinguish and crosslink multivalent saccharide ligands
or speciﬁc cell-surface arrays of glycoconjugates [6,7].
Information on carbohydrate-binding site recognition and
speciﬁc interactions with different sugars and glycans obtained by
X-ray crystallography can help establish correlations between cell-
surface binding activity and biological activities in different phys-
iological systems [8].
Diocleinae lectins are dimeric or tetrameric structures of dome-
shaped monomers consisting of jelly-roll motifs interconnected by
turns and loops [9]. According to Rangel and coworkers [10], DwL
weighs 25.6 kDa and features 237 residues per monomer. The
amino acid sequence identity between DwL (UniProtKB, with
accession P86624) [10] and DRL is 96%. Despite the considerable
similarity in primary and three-dimensional structure, the proteins
in this group differ substantially with regard to biological proper-
ties, making them excellent models for the study of structure/
function relationships [5,11].
Diocleinae lectins may produce either anti-inﬂammatory [12,13]
or pro-inﬂammatory effects [14,15], depending on the route of
administration. Sugar residues also play an important role, as
shown by the reversal of biological activities when lectins are
associated with their speciﬁc binding sugars. Several reports have
described pro-inﬂammatory activities (mast cell stimulation) for
Diocleinae lectins [16e18]. Mast cells are intimately involved in the
pathophysiology of allergic diseases and inﬂammation and their
activation promotes the release of chemical mediators responsible
for important tissue changes such as vasodilatation, increased
vascular permeability, bronchoconstriction and neutrophil or
eosinophil chemotaxis [19].
Thus, the objective of this study was to evaluate the pro- and
anti-edematogenic activity of a lectin isolated from the seeds of
Dioclea wilsonii and the correlation between crystal structure and
biological properties, including the participation of resident cells.
2. Materials and methods
2.1. Isolation of D. wilsonii lectin (DwL)
DwL was puriﬁed in two steps by dextran afﬁnity chromatog-
raphy on a Sephadex G-50 column followed by ion exchange
chromatography on HiTrap SP XL 01, as described by Rangel and
colleagues [10]. The apparent molecular weight of DwL and frag-
ments (b and g) was estimated by SDS-PAGE in the presence of b-
mercaptoethanol [20].
2.2. Crystallization and X-ray data collection
DwL was diluted homogenously to a concentration of 10.0 mg
mL1 in ultrapurewater and incubated during 1 hwith 3mMX-Man
(5-bromo-6-chloro-3-indolyl-alpha-D-mannopyranoside) for all
crystallization experiments. Crystallization conditions for DwL were
screened using the hanging-drop vapor diffusion method with
Hampton Research Crystal Screens I and II (Hampton Research,
Riverside, CA, USA) [21] at room temperature (293 K). Crystals were
obtained using condition #41 of Crystal Screen II (0.01 M Nickel (II),
0.1 M Tris pH 8.5, 1.0 M lithium sulfate monohydrate). Crystal
improvement was achieved by lowering the pH value to 8.0 of the
condition #41 [10].
X-ray data were collected from a single orthorhombic crystal
(point group I222) cooled to 100 K. Crystals were soaked in
a cryoprotectant solution containing 30% glycerol to avoid ice
formation and data were collected using synchrotron radiation
(MX1 station, National Laboratory of Synchrotron LighteLNLS,
Campinas, Brazil) of 1.47 Å wavelength. A complete data set was
obtained using a CCD detector (MAR Research) with 120 frameswith 40 s of exposure per frame and a 1 oscillation range. Data had
to be cut at 2.3 Å due to ice ring issues. I/sigma(I) was 0.0 in the next
shell (2.23 Å). The data set extending to a maximum resolution of
2.3 Å was indexed and integrated using XDS [22] and scaled with
SCALA [23].2.3. Molecular replacement and reﬁnement
The primary sequence of DwL was aligned with that of other
ConA-like lectins. Thus, the lectins of Dioclea violacea (DVL), Dioclea
guianensis (Dgui) and Dioclea rostrata (DRL) presented 96%, 95% and
96% identity with DwL, respectively [10]. DRL (PDB code: 2ZBJ) was
the best model in the molecular replacement study using Phaser
[24]. After this, it was observed Rfactor ¼ 0.3565 and Rfree ¼ 0.356.
Several rounds of iterative reﬁnement were performed with the
PHENIX suite [25], adding water molecules and deﬁning the
optimal X-ray weight. The residues GLY58, GLY70, VAL129, ASP192
and SER202 were replaced and the side chain conformations were
roughly adjusted to satisfy the electron density map. A total of 92
water molecules were added. Manual adjustments in Coot [26]
were made after each reﬁnement step and X-Man molecules
were manually added to the model. The structure was validated
using the MolProbity server [27]. The temperature factors for
ligands were 24.71 (X-Man) and 23.46 (Abu).2.4. Biological assays
2.4.1. Animals
Wistar rats (180e250 g) were kept in cages (6 in each) in
a controlled environment (circadian cycle, 25 C, food and water ad
libitum). The experimental protocols were approved by the Insti-
tutional Animal Care and Use Committee of the State University of
Ceará (UECE, Fortaleza, Ceará, Brazil) under No. 10130208-8/40,
following the recommendations of the Guide for the Care and Use
of Laboratory Animals of the US Department of Health and Human
Services (NIH publication No. 85e23, revised 1985).
2.4.2. Drugs and reagents
a-methyl-D-mannoside (a-CH3), D-glucose, indomethacin, Nu-
nitro-L-arginine methyl ester (L-NAME), pentoxifylline, pyrilamine,
thioglycolate, compound 48/80 and Evans blue were purchased
from Sigma (St. Louis, MO, USA). All drugs were solubilized directly
in sterile saline, except for indomethacin, which was initially dis-
solved in dimethyl sulfoxide up to 10% of the total volume, then in
saline.
2.4.3. Rat paw edema model
Paw volume was measured with a hydroplethysmometer at
baseline (immediately before s.c. injection of inﬂammatory stim-
ulants into the hind paw) and at 0.5, 1, 2e8 and 32 h. The results
were expressed as paw volume variation (mL) in relation to base-
line values. The area under the time-course curve (AUC) was
expressed in arbitrary units [28].
2.4.4. Evaluation of edematogenic activity
In order to evaluate the edematogenic effect of DwL, paw edema
was induced by s.c. injection of DwL (0.01, 0.1, 1 mg/kg) in a ﬁnal
volume of 0.1 mL/100 g body mass. The increase in vascular
permeability was indirectly measured by quantifying protein
leakage from inﬂamed paws [29] induced with 1 mg/kg DwL s.c.
The animals were injected i.v. with Evans blue (25 mg/kg) 1 h
before euthanasia, coinciding with the peak of edematogenic
activity. The paws were then sectioned at the ankle, weighed and
incubated with 2 mL formamide for 72 h at 37 C. The optical
Table 1
Statistics of data collection, reﬁnement and structure quality.
Parameters Values
Data collection
Beamline wavelength 1.42 Å
Space group I222
Unit cell parameters (Å)
a 58.8
b 66.8
c 107.3
Total reﬂections 45,720 (6659)d
Number of unique reﬂections 9392 (1381)d
Molecules per asymmetric unit Monomer
Resolution limits (Å) 19.4e2.3
Rmerge
a (%) 0.046 (0.099)d
Completeness (%) 97.0 (99.0)d
Multiplicity 4.9 (4.8)d
I/s (I) (Average) 9.0 (7.8)d
Molecular replacement
Log-likelihood gain 1299.86
RFZ 15.0
TFZ 30.1
Reﬁnement
Resolution range (Å) 19.4e2.3
Rfactor
b (%) 21.3
Rfree
c (%) 26.1
B factor (Å2) 24.3
Number of residues in asymmetric unit 237
Number of water molecules 92
RMS deviations
Bond length (Å) 0.009
Bond angle (degree) 1.357
Ramachandran plot
Residues in most favored regions (%) 96.9
Residues in additional allowed regions (%) 3.1
a
Rmerge ¼
P
hkl
P
i jIðhklÞ  hIðhklÞiijP
hkl
P
ihIðhklÞii
where I(hkl)i is the intensity of ith
measurement of the reﬂection h and I(hkl) is the mean value of the I(hkl)i for all I
measurements.
b Rfactor ¼
jFobsj  jFcalc j
jFobsj
.
c Calculated with 5% of the reﬂections omitted from reﬁnement.
d Values in parenthesis represent the high-resolution shell (2.4e2.3 Å).
Fig. 1. Interaction between X-Man and the residues of the carbohydrate-binding
domain of Dioclea wilsonii lectin. The ﬁgure shows 2foefc map countered at 1s for X-
Man and dash lines represent polar contacts between X-Man with CRD of DwL.
T.B.A. Rangel et al. / Biochimie 94 (2012) 525e532 527density (A600 nm) of the extracted dye was expressed as mean mg
Evans blue/g tissue  SEM.
To measure the anti-edematogenic effect of DwL, the most pro-
inﬂammatory concentration of DwLwas injected i.v. 30min prior to
s.c. administration of carrageenan (300 mg/paw), a well-known
phlogistic agent [30]. Following the same protocol, positive
controls received carrageenan while negative controls received
sterile saline only. An additional group of animals received the
stardard anti-inﬂammatory, dexamethasone (1 mg/kg, i.p.).
2.4.5. Modulation of edematogenic activity
The mechanism of edematogenesis was investigated by
administering indomethacin (5 mg/kg; s.c.), L-NAME (30 mg/kg;
i.v.) pyrilamine (10 mg/kg; i.p.) or pentoxifylline (90 mg/kg; s.c)
30 min prior to injection with 1 mg/kg DwL. The controls received
the same volume of sterile saline.
Compound 48/80 was injected i.p. over 4 days (on the ﬁrst 3
days at 0.6 mg/kg, then at 1.2 mg/kg) to achieve systemic mast cell
depletion. The animals also received thioglycolate i.p. for 4 days (on
the ﬁrst day at 3%/10 mL, then at 1.5%/10 mL) to induce systemic
increase in macrophage population [31,32]. The paws were injected
s.c. with DwL (1 mg/kg) 24 h after subchronic treatment with
compound 48/80 or thioglycolate. Controls were injected with
saline.
2.4.6. Investigation of the lectin domain involvement
DwL at the most pro-inﬂammatory dose was incubated with its
binding sugars glucose (0.5 M) or a-CH3 (1 M) for 1 h at 37 C to
allow for lectinesugar interaction before the experiment. Lectin
and sugar controls were incubated individually under similar
conditions.
2.4.7. Statistical analysis
Results were expressed as mean values  SEM for each group of
5e7 animals. Differences were analyzed with ANOVA or Student’s
t test, as appropriate. The level of statistical signiﬁcance was set at
p < 0.05.
3. Results
3.1. Puriﬁcation and crystallization of DwL
DwL was puriﬁed and crystallized as described by Rangel and
coworkers [10]. SDS-PAGE revealed the presence of DwL (25 kDa)
and fragments (b and g: 12 kDa).
The crystals belonged to point group I222. The Matthews coef-
ﬁcient [33] indicated the presence of a monomer in the asymmetric
unit. X-ray data collection statistics are shown in Table 1.
3.2. Overall structure of DwL
The structure of DwL was obtained by molecular replacement at
2.3 Å using the structure of DRL (PDB code: 2ZBJ) as search template
[34]. The structure was solved using the program Phaser [24] with
a maximum likelihood gain of 1299.86, RFZ of 15.0 and TFZ of 30.1
for the best solution. The reﬁned structure of tetrameric DwL was
determined by PISA, and presents 92 water molecules, one calcium
ion and one manganese ion per monomer. An X-Man molecule was
modeled into the carbohydrate recognition domain (CRD) (Fig. 1)
while a co-puriﬁed a-aminobutyric acid (Abu) molecule was
observed in the hydrophobic pocket, both according to the FoeFc
electronic density map. After the last reﬁnement of the structure,
Rfactor was 0.21 and Rfree was 0.26. The stereochemistry of the
structure was monitored with a Ramachandran plot, analyzing the
4 and j angles and the root mean square deviation of the bonds.The graph conﬁrmed the absence of residues in disallowed regions
and the deviations were within the normal range. Molecular
replacement and reﬁnement data are shown in Table 1. The struc-
ture factors and coordinates were deposited in the Protein Data
Bank under accession code number 3SH3.
Table 2
Van der Waals interaction and polar contacts between lectins of Dioclea wilsonii and
Dioclea violacea.
Amino acids X-Man D. wilsonii
PDB: 3SH3
D. violacea
PDB: 3AX4
Van der Waals interactions
TYR 12 CD2 O4 3.44 e
TYR 12 CD2 C6 e 3.43
TYR 12 OH C11 2.88 2.88
GLY 98 CA O6 3.21 2.96
GLY 98 C O6 3.39 3.28
LEU 99 CD2 C9 e 3.48
LEU 99 CD2 N1 e 3.40
ALA 207 CB C6 3.40 e
ALA 207 CB O6 3.04 3.26
ASP 208 CG O4 3.25 e
ASP 208 CG C6 e 3.49
ASP 208 OD1 C4 3.23 3.13
ASP 208 OD1 C6 3.39 3.07
ASP 208 OD2 C6 3.31 3.25
GLY 227 CA O3 e 3.25
ARG 228 CG O3 3.18 e
ARG 228 CB O4 3.27 3.27
Polar contacts
TYR 12 OH N1 3.23 3.06
ASN 14 N O4 2.82 e
ASN 14 ND2 O4 e 2.96
GLY 98 N O6 3.34 3.06
LEU 99 N O5 3.17 3.08
LEU 99 N O6 3.12 3.04
TYR 100 N O6 2.85 2.94
ASP 208 OD1 O4 e 2.63
TYR 100 O O6 3.12 3.04
ASP 208 OD1 O4 2.33 e
ASP 208 OD2 O6 2.70 e
ASP 208 OD2 O6 e 2.92
ARG 228 N O3 3.08 3.18
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the conserved residues ASN14 and TYR12 (which interact with
calcium), GLU8 and HIS24 (which interact with manganese) and
ASP10 and ASP19 (which interact with both). In addition, the
peptide bond of ALA207 and ASN208 in the cis conﬁguration is
isomerized due to the presence of divalentmetals changing the side
chain orientation of ASN14 and ASP208 [7].
The difference electron density map shows a feature in the
vicinity of LEU115, LEU126 and VAL179, corresponding to a non-
protein amino acid (Abu) commonly co-puriﬁed with Diocleinae
lectins [35]. The hydrophobic pocket shows a region accessible to
the solvent surface, allowing hydrophilic interactions to occur.
These hydrophilic interactions occur through hydrogen bonds
between the nitrogen atom in Abu and the nitrogen atom in HIS180
(main chain) at 2.7 Å, and between the oxygen atom in Abu and the
oxygen atom in SER125 (main chain) or the nitrogen atom in
SER125 (peptide bonds) at 3.1 Å. Abu also interacts with two water
molecules, involving oxygen and nitrogen at 2.7 Å and 2.8 Å,
respectively. In addition, Abu mediates between the components of
the canonical dimer, establishing hydrogen bonds with ASP139 and
SER129 (Fig. 2).
The carbohydrate-binding site is occupied by X-Man. DwL
interacts with mannose in much the same way as other ConA-like
lectins (Table 2). A structural comparison between DwL and DVL
(PDB code: 3AX4) can help clarify the interaction between DwL and
X-Man. By superimposing these structures, differences may be
observed in the interaction between X-Man and the hydrophobic
sub-site (Fig. 3). Thus, in DwL the side chain of LEU99 is positioned
at an angle preventing hydrophobic interaction. This could lead to
interaction with more complex carbohydrates d a process
requiring the involvement of this sub-site.ARG 228 N O4 3.43 3.233.3. Biological activities
DwL evoked dose-dependent paw edema at all doses tested,
beginning at 30 min, peaking at 4 h and subsiding at 24 h (Fig. 4A).
Injection of 0.01, 0.1 and 1 mg/kg DwL increased paw volume 4.8
times (AUC: 7.61  0.93), 5.7 times (AUC: 9.01  0.87) and 7 times
(AUC: 11.21  0.8), respectively, compared to saline (AUC:
1.58  0.63 arbitrary units) (Fig. 4B). The highest peak of paw
edema (1 mg/kg at 5 h) was paralleled by a 3-fold increase in
vascular permeability (67.2  3.5 mg) compared to saline
(21.29  10.9 mg Evans blue/g paw wet weight) (Fig. 4C). On theFig. 2. a-Aminobutyric acid (Abu) binding site. The electron density shows 2foefc map
countered at 1s for Abu and the amino acid residues involved in the site are also
demonstrated.
Fig. 3. Structural comparison between DwL (green) and DVL (PDB code: 3AX4, in blue).
Differences in the interaction between X-Man and the hydrophobic sub-site may be
observed after structures superimposition. In DwL, the side chain of Leu99 is positioned
at an angle preventing hydrophobic interactions. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 4. Dioclea wilsonii lectin induces paw edema and increase vascular permeability in rats. Animals were injected s.c. with DwL (0.01; 0.1; 1 mg/kg), carrageenan or saline (0.01 mL/
paw) and data expressed as the increase inpaw volume (mL) subtracted fromzero time (Panel A) or area under curve (arbitrary units) (Panels B andD). Animals receivedDwL s.c. (1mg/
kg) 4 h before Evans blue (25mg/kg, i.v.), sacriﬁced 1 h later for paw processing and data expressed as mg of Evans blue/g pawwetweight (Panel C). Animals were injected i.v. with DwL
(1mg/kg) or saline (0.01mL/paw) or i.p.with dexamethasone (1mg/kg) before s.c. injection of carrageenan (300 mg/pata) (Panel D). Edemawasmeasured before (time zero) and at½,1,
2e8 and 24 h after stimulus. Mean  S.E.M. (n ¼ 6). *p < 0.05 compared to saline; #p < 0.05 compared to DwL. DwL: lectin from Dioclea wilsonii; Cg: carrageenan.
T.B.A. Rangel et al. / Biochimie 94 (2012) 525e532 529other hand, i.v. injection of DwL (AUC: 14.01  0.87) did not inhibit
carrageenan-induced edema (AUC: 15.2  0.8) (Fig. 4D).
The edematogenic effect of saturated solution of DwL with
glucose (AUC: 3.43  0.1) or a-CH3 (AUC: 3.72  0.2) was similar to
that of DwL (AUC: 3.31  0.14) (Fig. 5A) per se. Neither glucose
(AUC: 0.20  0.05) nor a-CH3 (AUC: 0.22  0.03) induced edema
when administered alone compared to saline (AUC: 0.19  0.08
arbitrary units).
The administration of pyrilamine (histamine antagonist)
reduced the edematogenic effect of DwL (AUC: 2.71  0.19) by
47% (AUC: 1.44  0.29); indomethacin (non-speciﬁc enzyme
cyclooxygenase inhibitor) by 32% (AUC: 1.85  0.18); L-NAME (non-
selective NOS inhibitor) by 31% (AUC: 1.99  0.17) and pentoxifyl-
line (non-speciﬁc cytokine inhibitor) by 53% (AUC: 1.28  0.21
arbitrary units) (Fig. 5B), suggesting an edematogenesis mediated
by mechanisms involving histamine, prostaglandins, nitric oxide,
IL-1 and TNF-a.
The edematogenic effect of DwL was reduced about 65% (AUC:
3.29  0.18) by mast cell depletion evoked with compound 48/80
(AUC: 1.02  0.08), but not by thioglycolate-induced macrophage
accumulation (AUC: 2.85  0.17) (Fig. 5C).
4. Discussion
Like most legume lectins, DwL has a protein chain in the
asymmetric unit featuring 237 residues. Diocleinae lectins consist
of one intact subunit (a) and two fragments (b and g) originated
from the post-translational processing of the lectin precursorduring seed development [10]. The mannose moiety of X-Man
binds to the CRD, stabilizing the protein. This leads to a more highly
ordered crystal arrangement allowing the formation of better-
quality crystals, as observed for other legume lectins such as Par-
kya plathycephala lectin e PPL [36].
Being a tetramer, DwL is formed by the intersection of two
perpendicular crystallographic two-fold axes and consists of two
dimers in canonical b-sheet conformation. Referred to as “jelly-
roll”, this quaternary arrangement is found in all ConA-like lectins.
Abu has previously been identiﬁed in lectins, including CGL [35]
and ConBr [37]. It has been suggested this interaction is part of
a plant defense mechanism.
In respect to lectin effect in the inﬂammatory process, DwL
displayed edematogenic activity paralleled by increased vascular
permeability, but failed to produce anti-inﬂammatory effects.
Diocleinae lectins may produce either anti-inﬂammatory [12,13] or
pro-inﬂammatory effects [14,15,38] depending on the route of
administration. However, for some lectins, such as DwL, no anti-
inﬂammatory activity has yet been observed. The same is
observed for the lectins of Canavalia brasiliensis (ConBr) and Dioclea
grandiﬂora [13], the later shows 99% of identity with DwL. The
edematogenic effect of DwL was of short duration, representing
a typical manifestation of acute inﬂammation like other Diocleinae
lectins.
Several studies have shown that resident cells may participate in
leukocyte recruitment via synthesis of inﬂammatory mediators
[39e41]. In our study, DwL-induced edema was reversed by
treatment with compound 48/80, but not with thioglicolate, which
Fig. 5. Mechanisms involved in the edema induction by Dioclea wilsonii lectin. DwL
(1 mg/kg) alone or associated with 0.5 M Glucose or 1 M a-CH3 was administered s.c.
(Panel A). Pyrilamine (10 mg/kg; i.p.), L-NAME (30 mg/kg; i.v.), indomethacin (5 mg/kg;
s.c.) or pentoxifylline (90 mg/kg; s.c) were injected in single doses 30 min before DwL
(Panel B). Animals received i.p. compound 48/80 (at 0.6 mg/kg on the ﬁrst 3 days and
at 1.2 mg/kg on the day 4) or thioglycolate (in the ﬁrst day at 3% and in the following
days at 1.5%) over 4 days. 24 h later, normal or pre-treated rats were injected with DwL
(1 mg/kg; s.c.) (Panel C). Negative controls received saline (0.1 ml/100 g body weight;
s.c.); positive controls received DwL s.c. only. Edema was measured before (time zero)
and at ½, 1, 2, 3, 4, 5, 6 after DwL. Means  SEM (n ¼ 6) as area under curve (AUC-
arbitrary units). *p < 0.05 compared to saline; #p < 0.05 compared to DwL.
Table 3
Comparison between anti and pro-inﬂammatory effects of Diocleinae lectins.a
Lectin Time of
edema peak
Increase
of edema
Anti-inﬂammatory
effect
ConBr ½ h 8 No
CGL ½ h 6 N.I.
ConM ½ h 5 N.I.
ConA ½ h 3 N.I.
CRL I 4th h 6 Yes
DVL N.I. N.I. Yes
D. virgata 1st h 4 Yes
Dgui N.I. N.I. Yes
DGF 5th h 5 No
DwL 5th h 12 No
N.I.: not investigated.
a Adapted from [6,11,12,15,39].
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mast cell activation could be implied in the neutrophil recruitment
to rat peritoneal cavity induced by DwL [10]. Our ﬁndings are
supported by several studies on mast cell recruitment promoted byplant lectins: Araucaria angustifola lectin, a GlcNAc-binding protein,
produced edematogenic effect via activation of inﬂammatory
mediators from resident mast cells [42]; the plant lectin KMþ was
observed to activate and degranulate mast cells, providing an
ampliﬁcation loop for the neutrophil recruitment induced by this
lectin [43]; and Diocleinae lectins (ConM, ConA, ConBr, DvirL, DRL,
DVL, Dgui and CRL I) have been observed to induce histamine
release in rat peritoneal mast cells [16e18,44].
Carbohydrate recognition is the main activity and potential
biotechnological application of Diocleinae lectins. The importance
of carbohydrate sites has also been demonstrated for a range of
effects produced by Diocleinae lectins in inﬂammation models
[12,13,15,38]. However, saturated solution of ConA and ConBr with
glucose also released histamine from Wistar rat peritoneal mast
cells [16]. Likewise, our results show that the edematogenic activity
of DwLwas not reversed by its binding sugars, suggesting that mast
cell activation involves interactions with complex glycans that
commonly depend on nonpolar interactions (Table 2). The observed
interaction between DwL and X-Man sheds light on some impor-
tant aspects of carbohydrate recognition by ConA-like lectins in
general. The number of hydrogen bonds in DwL is similar to that of
previously described members of the genus Dioclea (Table 2), but
a comparison of the structures of DwL and DVL reveals important
differences in hydrophobic and Van derWaals interactions (Table 2)
(Fig. 1). Different from lectins of Canavalia genus, which show
a peak of edema at the ﬁrst half an hour, DwL showed a later peak of
edematogenic activity, in accordance with other lectins of the same
genus (Table 3). Differences in interaction patterns between the
X-Man indolyl group and LEU99 are due to differences in the LEU99
side chain conformation of DVL and DwL. Thus, the two interactions
with CD2 and the binding-enhancing hydrophobic contacts
observed in DVL are absent in DwL (Fig. 3). This can explain why
despite high identity of DwL with DVL (99% e SwissProt accession
code: P58909) and Dgui (95% e SwissProt accession code: P81637)
[10], DwL do not present anti-inﬂammatory effect [13] (Table 3).
Comparing DwL edematogenic effect with other Diocleinae lectins,
it can be observed that DwL show the best potency, increasing the
edema in 12 times in relation to controls (Table 3). The conforma-
tion of the hydrophobic sub-site in DwL together with lack of
afﬁnity for monosaccharides may explain why this lectin interac-
tion with complex glycans in mast cells lead to better efﬁcacy for
edematogenic activities andwhy themonosaccharideswere unable
to prevent the edematogenic effect of this lectin.
DVL and DwL also differ in the position 161. DVL contains
a serine, and DwL contains an asparagine, although it is located
about 24 Å of the monosaccharide binding site. This difference
might be important when it comes to interaction with complex
carbohydrates, since the activities seem to be caused by interactions
with complex carbohydrates, as indicated by the reverse assays. It is
Table 4
Distances between residues of the carbohydrate-binding domain of lectins from
genus Dioclea.
Residues Distance (Å)
DWL DVL DRL
ARG 228 N e TRY 12 OH 9.91 9.55 9.00
ARG 228 N e ASN 14 ND2 4.69 4.86 3.79
TYR 100 N e TYR 12 OH 7.23 6.91 7.30
TYR 100 N e LEU 99 N 2.71 2.65 2.78
TYR 12 OH e ASN 14 ND2 5.32 5.36 5.77
ARG 228 N e LEU 99 N 9.37 10.25 9.80
ARG 228 N e TYR 100 N 11.51 11.82 11.07
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the monosaccharide binding site drastically affects biological
activities in Diocleinae lectins [15]. In this study, we report the same
feature but occurring relativity distant of the monosaccharide
binding site, which goes with the fact that the biological activities
presented here are caused by complex carbohydrates.
DwL seems to interact with complex carbohydrates in mast cells
surface, which in turn release mediators producing symptoms of
inﬂammation, including vasodilatation, plasma extravasation and
neutrophil migration. In this study, pre-treatment of rats with
a prostaglandin and thromboxane blocker e indomethacin [45], an
NOS inhibitor e L-NAME [46], an H1 histamine receptor antagonist e
pyrilamine [47] and a pro-inﬂammatory cytokine expression down-
regulator e pentoxifylline [48] reduced the edematogenic effect of
DwL, evidencing the involvementof prostaglandin, NO, histamine and
cytokines (TNF-a and IL-1b). Upon being activated, mast cells possess
the ability to release mediators e both preformed and newly
synthesized e which serve to alert the immune response or amplify
an existing response. Granule-associated mediators, including prote-
ases, histamine, proteoglycans and cytokines (eg TNF-a) are released
immediately upon activation, being critical for initiating mast cell-
mediated innate immune responses. Newly synthesized mediators
include lipids, cytokines and chemokines [19,49,50]. Lipid mediators
such as leukotriene C4, leukotriene B4 and prostaglandin D2 are
involved in various allergic and pro-inﬂammatory responses [49,50].
Mast cells produce various cytokines ranging from pro-inﬂammatory
cytokines (eg TNF-a, IL-6 and IL-1b) to several chemokines (eg CCL5
andCXCL8),which recruit immune cells to the site of infection. Finally,
mast cells arephagocytic andproducenitric oxide, superoxide radicals
and antimicrobial peptides, such as cathelicidins [19,51].
Conformational changes in the hydrophobic sub-site have
consistently been associated with the strengthening or weakening
of interactions between glycans and lectins [3,6]. Another inter-
esting structural aspect reported for legume lectins is the CRD
conformation in lectins of the genus Canavalia. It has been sug-
gested that certain geometric aspects of the CRD are related to cell
recognition and the effect of these lectins on endothelial cells [52].
A comparison of three lectins of the genus Dioclea revealed
discrepancies (Table 4) similar to those previously described for
DVL and DRL using the same experimental model. However, the
present study is to our knowledge the ﬁrst to establish three-
dimensional structural/functional relationships using a model of
edematogenesis. These discrepancies in geometric aspects of the
CRD can be involved in differences in inﬂammation induced by
lectins of the Dioclea genus. For example, it should explainwhy DRL
induces neutrophil migration via macrophage activation [14] while
DwL via activation of mast cells.
5. Conclusion
DwL differs structurally from DVL and DRL with regard to the
conformation of the carbohydrate recognition domain and relatedbiological activities. The mechanism of edematogenic activity
in DwL appears to involve positive modulation of mast cell
degranulation via recognition of surface carbohydrates. Since this
recognition is dependent on site volume and CRD conﬁguration,
edematogenesis mediated by resident cells varies in potency and
efﬁcacy among different Diocleinae lectins.Acknowledgments
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